Last reviewed · How we verify
Beta-3 Agonists, Adrenergic
Beta-3 Agonists, Adrenergic is a Small molecule drug developed by Baylor Research Institute. It is currently FDA-approved. Also known as: Mirabegron, Myrbetriq.
At a glance
| Generic name | Beta-3 Agonists, Adrenergic |
|---|---|
| Also known as | Mirabegron, Myrbetriq |
| Sponsor | Baylor Research Institute |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists (PHASE1)
- TReating Incontinence for Underlying Mental and Physical Health (PHASE4)
- Vibegron for ENergy Thinking and Resilience in Aging (PHASE3)
- Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence (PHASE4)
- Efficacy of Low-Intensity Shockwave Therapy in Treating Radiation Cystitis (EARLY_PHASE1)
- Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder (PHASE4)
- Assessment of Efficacy of Mirabegron, a New beta3-adrenergic Receptor in the Prevention of Heart Failure (PHASE2)
- Composur: Study to Understand the Performance of Vibegron in Participants with Overactive Bladder (OAB)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Beta-3 Agonists, Adrenergic CI brief — competitive landscape report
- Beta-3 Agonists, Adrenergic updates RSS · CI watch RSS
- Baylor Research Institute portfolio CI
Frequently asked questions about Beta-3 Agonists, Adrenergic
What is Beta-3 Agonists, Adrenergic?
Beta-3 Agonists, Adrenergic is a Small molecule drug developed by Baylor Research Institute.
Who makes Beta-3 Agonists, Adrenergic?
Beta-3 Agonists, Adrenergic is developed and marketed by Baylor Research Institute (see full Baylor Research Institute pipeline at /company/baylor-research-institute).
Is Beta-3 Agonists, Adrenergic also known as anything else?
Beta-3 Agonists, Adrenergic is also known as Mirabegron, Myrbetriq.
What development phase is Beta-3 Agonists, Adrenergic in?
Beta-3 Agonists, Adrenergic is FDA-approved (marketed).
Related
- Manufacturer: Baylor Research Institute — full pipeline
- Also known as: Mirabegron, Myrbetriq
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing